What the August 2026 Cases Actually Say About “Research Use Only” Sales
Status: August 14, 2026
THE KEY POINT
Eli Lilly has filed lawsuits against several companies selling retatrutide labeled or represented as “Research Use Only” (RUO).
However, Lilly's complaints do not simply argue:
Instead, Lilly alleges that these particular companies were actually intending and marketing retatrutide for human use, despite displaying RUO / “Not for Human Consumption” disclaimers.
Lilly...
